Cite
Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation.
MLA
Cavattoni, Irene, et al. “Pilot Study of Rituximab plus Donor-Lymphocyte Infusion to Prevent or Treat Relapse in B-Cell Lymphoma after Allogeneic Stem Cell Transplantation.” Leukemia & Lymphoma, vol. 51, no. 1, Jan. 2010, pp. 146–48. EBSCOhost, https://doi.org/10.3109/10428190903275594.
APA
Cavattoni, I., Zabelina, T., Ayuk, F., Wolschke, C., Bacher, U., Zander, A., & Kröger, N. (2010). Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation. Leukemia & Lymphoma, 51(1), 146–148. https://doi.org/10.3109/10428190903275594
Chicago
Cavattoni, Irene, Tatjana Zabelina, Francis Ayuk, Christine Wolschke, Ulrike Bacher, Axel Zander, and Nicolaus Kröger. 2010. “Pilot Study of Rituximab plus Donor-Lymphocyte Infusion to Prevent or Treat Relapse in B-Cell Lymphoma after Allogeneic Stem Cell Transplantation.” Leukemia & Lymphoma 51 (1): 146–48. doi:10.3109/10428190903275594.